LAPTM4A and glioblastoma: The results demonstrated a positive association between LAPTM4A expression and immunological, stromal, and estimation scores across LGG, GBM, and GBMLGG, with a particularly noteworthy correlation observed in GBMLGG (correlation coefficient >0.5).